Sign in
Taking people in PolandPhase 1

Study of how QL0911 moves through and acts in the body

Tests QL0911 in adults, looking at how the body handles it.

Key facts

Who runs it
Qilu Pharmaceutical Co. Ltd.
Where
Warsaw, PolandSee the site
Registry title
A Phase 1, Randomized, Double-Blind, Two-Arm, Two-Way Crossover Study of Pharmacokinetics and Pharmacodynamics of QL0911
Status
Recruiting
Phase
Phase 1
People taking part
76 people, planned
Started
4 Sept 2026
Expected to end
20 Jun 2027
Type of study
Interventional
Record updated
6 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 64 to study how QL0911 moves through and acts in the body. Healthy volunteers can join.

Age
18 Years to 64 Years
Sex
All sexes can join

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Where in Poland

  • MTZ Clinical Research powered by PratiaWarsaw, PolandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
Study of how QL0911 moves through and acts in the bodyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from 2025-523355-59-00, who can take part
Record updated
6 July 2026